Living with diabetes requires meticulous blood sugar management. Traditional insulin therapies, while effective, often carry ...

A Calgary biotech company using genetically modified safflower plants to make insulin will get US$2.5 million for the option to buy the rights to its end product. MannKind, a Los Angeles-area ...

slim X2 insulin pump with Eli Lilly’s ultra-rapid acting insulin, Lyumjev, in the European Union (EU). The compatibility with ...

Enrique Conterno, president, Lilly Diabetes said that an ultra-rapid acting insulin would be a "natural fit" in the company's growing portfolio. In September, the Lilly-Boehringer Ingelheim ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Wockhardt Limited, the global pharmaceutical company, has submitted its indigenously developed fast-acting insulin analog, ASPARAPID, for regulatory approval with India’s Drugs Controller ...

These findings may usher in a new era in diabetes treatment without ... of hypoglycaemia and partly covering the need for fast-acting insulin at mealtime. The combination of these two features ...

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin ... way in which the FDA's new commissioner Scott Gottlieb ...

Drugmaker Wockhardt has approached the Drug Controller General of India (DCGI) seeking approvals for its fast-acting insulin analog, Aspart injection. The company’s Aspart insulin injection ...